Over the last 7 days, the Biotech industry has dropped 1.4%, driven by CSL declining 1.8%. The industry has fallen 7.9% in the last year. Earnings are forecast to grow by 16% annually.
Has the Australian Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Thu, 23 May 2024 | AU$144.5b | AU$22.1b | AU$3.2b | 30.6x | 44.9x | 6.6x |
Sat, 20 Apr 2024 | AU$140.0b | AU$22.9b | AU$3.4b | 29.7x | 41.7x | 6.1x |
Mon, 18 Mar 2024 | AU$143.3b | AU$22.4b | AU$3.3b | 30.5x | 43.7x | 6.4x |
Wed, 14 Feb 2024 | AU$143.8b | AU$22.4b | AU$3.3b | 31x | 43.7x | 6.4x |
Fri, 12 Jan 2024 | AU$148.3b | AU$20.5b | AU$2.7b | 34.7x | 54.7x | 7.2x |
Sun, 10 Dec 2023 | AU$135.8b | AU$20.9b | AU$2.8b | 33.8x | 49.1x | 6.5x |
Tue, 07 Nov 2023 | AU$126.2b | AU$21.1b | AU$2.8b | 30.4x | 44.9x | 6x |
Thu, 05 Oct 2023 | AU$126.1b | AU$21.7b | AU$2.9b | 28.7x | 43.6x | 5.8x |
Sat, 02 Sep 2023 | AU$137.4b | AU$21.2b | AU$2.8b | 34x | 49.6x | 6.5x |
Mon, 31 Jul 2023 | AU$137.8b | AU$18.1b | AU$2.3b | 37.4x | 59x | 7.6x |
Wed, 28 Jun 2023 | AU$143.3b | AU$18.0b | AU$2.3b | 37.1x | 61.8x | 8x |
Fri, 26 May 2023 | AU$156.4b | AU$18.3b | AU$2.4b | 41x | 66x | 8.5x |
Sun, 23 Apr 2023 | AU$154.4b | AU$18.0b | AU$2.3b | 41.8x | 66.7x | 8.6x |
Tue, 21 Mar 2023 | AU$145.3b | AU$17.9b | AU$2.3b | 39.9x | 62.7x | 8.1x |
Thu, 16 Feb 2023 | AU$154.9b | AU$17.3b | AU$2.3b | 52.2x | 67.9x | 9x |
Sat, 14 Jan 2023 | AU$144.6b | AU$15.5b | AU$2.5b | 50.1x | 58.9x | 9.3x |
Mon, 12 Dec 2022 | AU$152.4b | AU$15.8b | AU$2.5b | 47.9x | 60.6x | 9.6x |
Wed, 09 Nov 2022 | AU$142.0b | AU$16.7b | AU$2.7b | 42.6x | 53.2x | 8.5x |
Fri, 07 Oct 2022 | AU$147.9b | AU$16.6b | AU$2.7b | 43.4x | 55.3x | 8.9x |
Sun, 04 Sep 2022 | AU$150.7b | AU$15.7b | AU$2.5b | 44.4x | 60.3x | 9.6x |
Tue, 02 Aug 2022 | AU$154.2b | AU$15.5b | AU$2.8b | 40x | 55.4x | 10x |
Thu, 30 Jun 2022 | AU$135.9b | AU$15.6b | AU$2.8b | 34.7x | 48.4x | 8.7x |
Sat, 28 May 2022 | AU$136.2b | AU$15.3b | AU$2.7b | 35.5x | 49.7x | 8.9x |
Mon, 25 Apr 2022 | AU$137.7b | AU$14.8b | AU$2.7b | 38x | 51.1x | 9.3x |
Wed, 23 Mar 2022 | AU$135.6b | AU$14.5b | AU$2.6b | 40x | 51.6x | 9.3x |
Fri, 18 Feb 2022 | AU$143.0b | AU$15.0b | AU$2.7b | 41.2x | 52.8x | 9.5x |
Sun, 16 Jan 2022 | AU$143.5b | AU$14.5b | AU$2.8b | 40.2x | 52x | 9.9x |
Tue, 14 Dec 2021 | AU$148.0b | AU$14.6b | AU$2.8b | 40.9x | 53.2x | 10.1x |
Thu, 11 Nov 2021 | AU$156.4b | AU$14.2b | AU$2.7b | 44.4x | 58.2x | 11x |
Sat, 09 Oct 2021 | AU$144.5b | AU$14.3b | AU$2.7b | 40.8x | 53.5x | 10.1x |
Mon, 06 Sep 2021 | AU$151.7b | AU$14.0b | AU$2.6b | 44x | 57.8x | 10.9x |
Wed, 04 Aug 2021 | AU$143.8b | AU$14.0b | AU$2.6b | 42x | 54.8x | 10.3x |
50.3x
Which industries have driven the changes within the Australian Healthcare industry?
AU Market | 1.11% | |
Healthcare | -2.18% | |
Biotech | -1.41% | |
Biotech | -1.41% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
TLX Telix Pharmaceuticals | AU$15.78 | 4.7% +AU$292.6m | 37.2% | PE1011.8x | |
MSB Mesoblast | AU$1.15 | 9.5% +AU$114.1m | 9.0% | PS117.1x | |
IMM Immutep | AU$0.47 | 6.7% +AU$35.7m | 33.8% | PS143.7x | |
ATH Alterity Therapeutics | AU$0.006 | 20.0% +AU$5.2m | -14.3% | PS9.2x | |
ARX Aroa Biosurgery | AU$0.49 | 3.1% +AU$5.2m | -45.0% | PS2.7x |